Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/25 17:17 | 3/3/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Nguyen Anhco | CA | DO | P,CEO | 6 | S | -92 | 1.32 | 0 | -69 | 941 | D | |||||||||||||||
3/5/25 17:17 | 3/3/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Hyllengren Eric J | CA | O | EVP,CFO, | 6 | S | -58 | 1.14 | 0 | -51 | 674 | D | |||||||||||||||
3/5/25 17:16 | 3/3/25 | ATRA | Health | BioPrd | Biological Products, (No Diag | Henrich Jill | CA | O | EVP,Chie | 6 | S | -45 | 1.25 | 0 | -36 | 555 | D | |||||||||||||||
8/20/24 18:27 | 8/16/24 | ATRA | Health | BioPrd | Biological Products, (No Diag | Touchon Pascal | CA | DO | P,CEO | 4 | S | -96 | 0.7416 | 0 | -130 | 1,911 | D | |||||||||||||||
8/20/24 18:27 | 8/16/24 | ATRA | Health | BioPrd | Biological Products, (No Diag | Murugan Amar | CA | O | EVP,GC | 3 | S | -31 | 0.7380 | 0 | -42 | 695 | D | |||||||||||||||
11/20/23 17:30 | 11/16/23 | ATRA | Health | BioPrd | Biological Products, (No Diag | Joshi Manher | CA | O | EVP,Chie | 1 | S | -5 | 0.3890 | 0 | -12 | 171 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |